BALA CYNWYD, Pa.--(BUSINESS WIRE)--Jan. 26, 2006--Duska Therapeutics, Inc. (OTCBB:DSKT), a development-stage biopharmaceutical company focused on ATP-related diagnostic and therapeutic technologies, today announced that Sanford J. Hillsberg has voluntarily resigned from the Company’s Board of Directors. The Company expects to announce a replacement for Mr. Hillsberg shortly.
